Literature DB >> 26767172

One-stop TB-HIV services evaluation in Rwanda: comparison of the 2001-2005 and 2006-2010 cohorts.

A Ndagijimana1, E Rugigana1, C B Uwizeye2, J Ntaganira1.   

Abstract

BACKGROUND: Tuberculosis (TB) and human immunodeficiency virus (HIV) co-infection remains high in Rwanda. Since one-stop TB-HIV services were implemented to manage TB-HIV co-infection, their functioning and impact on TB treatment outcomes have not been assessed.
OBJECTIVE: To evaluate one-stop TB-HIV services in Rwanda by comparing the TB treatment outcomes before and after their implementation in Kicukiro and Rulindo districts.
METHODS: This descriptive retrospective study used a quantitative questionnaire to determine the functioning of Rwanda's one-stop TB-HIV services. In-depth interviews and focus group discussions with health care providers, heads of facilities and co-infected patients were held to seek their opinion about the functioning of the services.
RESULTS: The one-stop TB-HIV services at all 12 health facilities visited were functioning according to the approved criteria. However, TB treatment outcomes after the intervention were not statistically different from those before the intervention. Qualitative data showed a positive impact on the quality of service, particularly a reduction in waiting times and appointments that were better respected as a result of the efficient functioning of the services.
CONCLUSION: One-stop TB-HIV services have improved the quality of service in Kicukiro and Rulindo districts. However, the services need to be strengthened programmatically to improve TB treatment outcomes.

Entities:  

Keywords:  LMICs; programme evaluation; services integration

Year:  2015        PMID: 26767172      PMCID: PMC4682610          DOI: 10.5588/pha.15.0093

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  17 in total

1.  Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis--a randomised trial.

Authors:  T Schön; J Idh; A Westman; D Elias; E Abate; E Diro; F Moges; A Kassu; B Ayele; T Forslund; A Getachew; S Britton; O Stendahl; T Sundqvist
Journal:  Tuberculosis (Edinb)       Date:  2011-08-02       Impact factor: 3.131

2.  Reducing mortality from HIV infection and tuberculosis.

Authors:  Olivier Koole; Robert Colebunders
Journal:  Lancet Infect Dis       Date:  2011-04-20       Impact factor: 25.071

3.  TB diagnostic capacity in sub-Saharan African HIV care settings.

Authors:  Suzue Saito; Andrea A Howard; Michael J A Reid; Batya Elul; Anna Scardigli; Sabine Verkuijl; Alaine U Nyaruhirira; Denis Nash
Journal:  J Acquir Immune Defic Syndr       Date:  2012-10-01       Impact factor: 3.731

Review 4.  Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review.

Authors:  Jennifer Uyei; David Coetzee; James Macinko; Sally Guttmacher
Journal:  Lancet Infect Dis       Date:  2011-11       Impact factor: 25.071

5.  Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study.

Authors:  S M Hermans; F van Leth; Y C Manabe; A I M Hoepelman; J M A Lange; A Kambugu
Journal:  HIV Med       Date:  2012-02-02       Impact factor: 3.180

6.  Clinical predictors for death in HIV-positive and HIV-negative tuberculosis patients in Guinea-Bissau.

Authors:  P Gustafson; V F Gomes; C S Vieira; B Samb; A Nauclér; P Aaby; I Lisse
Journal:  Infection       Date:  2007-04       Impact factor: 3.553

7.  Integrating tuberculosis and HIV care in rural Rwanda.

Authors:  M Gasana; G Vandebriel; G Kabanda; S J Tsiouris; J Justman; R Sahabo; D Kamugundu; W M El-Sadr
Journal:  Int J Tuberc Lung Dis       Date:  2008-03       Impact factor: 2.373

8.  Reaching the targets for tuberculosis control: the impact of HIV.

Authors:  K F Laserson; C D Wells
Journal:  Bull World Health Organ       Date:  2007-05       Impact factor: 9.408

9.  Health system barriers affecting the implementation of collaborative TB-HIV services in Uganda.

Authors:  R Okot-Chono; F Mugisha; F Adatu; E Madraa; R Dlodlo; P Fujiwara
Journal:  Int J Tuberc Lung Dis       Date:  2009-08       Impact factor: 2.373

10.  Evaluation of the rapid scale-up of collaborative TB/HIV activities in TB facilities in Rwanda, 2005-2009.

Authors:  Eric S Pevzner; Greet Vandebriel; David W Lowrance; Michel Gasana; Alyssa Finlay
Journal:  BMC Public Health       Date:  2011-07-11       Impact factor: 3.295

View more
  5 in total

1.  Effect of TB/HIV Integration on TB and HIV Indicators in Rural Ugandan Health Facilities.

Authors:  Sarah M Burnett; Stella Zawedde-Muyanja; Sabine M Hermans; Marcia R Weaver; Robert Colebunders; Yukari C Manabe
Journal:  J Acquir Immune Defic Syndr       Date:  2018-12-15       Impact factor: 3.731

2.  Service integration to reduce HIV-associated TB mortality.

Authors:  Nathan Ford; Haileyesus Getahun
Journal:  Public Health Action       Date:  2015-12-21

3.  Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South Africa.

Authors:  Peter Bock; Geoffrey Fatti; Nathan Ford; Karen Jennings; James Kruger; Colette Gunst; Françoise Louis; Nelis Grobbelaar; Kwame Shanaube; Sian Floyd; Ashraf Grimwood; Richard Hayes; Helen Ayles; Sarah Fidler; Nulda Beyers
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

4.  Integrating HIV services and other health services: A systematic review and meta-analysis.

Authors:  Caroline A Bulstra; Jan A C Hontelez; Moritz Otto; Anna Stepanova; Erik Lamontagne; Anna Yakusik; Wafaa M El-Sadr; Tsitsi Apollo; Miriam Rabkin; Rifat Atun; Till Bärnighausen
Journal:  PLoS Med       Date:  2021-11-09       Impact factor: 11.069

5.  Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.

Authors:  Peter Bock; Karen Jennings; Redwaan Vermaak; Helen Cox; Graeme Meintjes; Geoffrey Fatti; James Kruger; Virginia De Azevedo; Leonard Maschilla; Francoise Louis; Colette Gunst; Nelis Grobbelaar; Rory Dunbar; Mohammed Limbada; Sian Floyd; Ashraf Grimwood; Helen Ayles; Richard Hayes; Sarah Fidler; Nulda Beyers
Journal:  J Acquir Immune Defic Syndr       Date:  2018-01-01       Impact factor: 3.731

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.